David R. Langley - Concepedia

Author

David R. Langley

Bristol-Myers Squibb (United States)ORCID

Also Known As

D Langley, D. Langley, D. R. LANGLEY, D. R. Langley, D.R. Langley, DAVID R. LANGLEY, David Langley, David R Langley, David R. Langley, Langley, D.R.

136

Publications

8.3K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

David R. Langley is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	43	3.4K
2	Natural Sciences	26	34	2.1K
3	Engineering	6	6	321
4	Health Sciences	1	1	17
5	Allergy	1	1	59

David R. Langley

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Min Gao, Richard E. Nettles, Makonen Belema, Nature Hcv Ns5a InhibitorViral HepatitisMedicineAntiviral Drug DevelopmentAntiviral Therapy	2010	929
Selective Interactions of Cationic Porphyrins with G-Quadruplex Structures Haiyong Han, David R. Langley, Anupama Rangan, Journal of the American Chemical Society	2001	318
Inhibition of Hepatitis B Virus Polymerase by Entecavir David R. Langley, Ann W. Walsh, Carl J. Baldick, Journal of Virology Viral ReplicationBiochemistryViral HepatitisNatural SciencesAntiviral Drug Development	2007	187
Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions Qi Guo, Hsu‐Tso Ho, Ira B. Dicker, Journal of Virology ImmunologyMolecular BiologyBms-378806 BindsAntiviral DrugHuman Retrovirus	2003	167
Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds Laurence H. Hurley, Teri Reck, David E. Thurston, Chemical Research in Toxicology	1988	139
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers Samuel W. Gerritz, Christopher Cianci, Sean Kim, Proceedings of the National Academy of Sciences Viral RnaVirus StructureViral ReplicationBiochemistrySynthetic Virology	2011	136
Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir Nicholas A. Meanwell, Mark Krystal, Beata Nowicka-Sans, Journal of Medicinal Chemistry ImmunologyPharmacotherapyAntiviral DrugMedicinal ChemistryAntiviral Drug Development	2017	136
A General Amino Acid Synthesis Enabled by Innate Radical Cross‐Coupling Shengyang Ni, Alberto F. Garrido‐Castro, Rohan R. Merchant, Angewandte Chemie International Edition Molecular BiologyOrganic ChemistryPeptide ScienceProtein SynthesisMedicinal Chemistry	2018	135
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529 Marie Pancera, Yen‐Ting Lai, Tatsiana Bylund, Nature Chemical Biology Crystal StructureMedicineAntiviral Drug DevelopmentMolecular BiologyEntry Inhibitors Bms-378806	2017	127
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models Sheryl M. Gough, John J. Flanagan, Jessica L.F. Teh, Clinical Cancer Research	2024	120

Page 1